Medical Monitoring Articles

First-in-man demonstration of 18-month spatiotemporal stability of active atrial fibrillation source detected by Electrographic Flow mapping in persistent atrial fibrillation

Keywords: atrial fibrillation, catheter ablation, mapping, atrial fibrillation, source, electrographic flow Introduction: Advanced mapping methods for atrial fibrillation (AF) have previously suffered from poor spatiotemporal stability. Electrographic flow (EGF) mapping is a novel technique using computer vision and optical flow smoothing algorithms to avoid this issue. The aim of this ...

Jun. 13, 2021

By Ablacon, Inc.

Getting Together: How GE`s Health Innovation Village Used Tech to Help Seniors During the Pandemic

The COVID-19 pandemic forced companies the world over to adapt. For a diverse group of Finnish technology businesses, it also opened doors to a market that tech entrepreneurs sometimes ignore: seniors. Brought together by their membership in GE’s Health Innovation Village in Helsinki, the leaders of these small but growing firms noticed a paradox. COVID-19 left the elderly more isolated ...

Jun. 8, 2021

By GE Renewable Energy

Accurate Tracking of Pressor and Fluid Changes - Case Study

A head-to-head comparison undertaken during liver transplant in a 66 year-old woman demonstrates that the Retia Argos Monitor accurately tracks pressor and fluid changes where the leading competitor monitor fails. As shown, the Retia Monitor accurately tracks the discordant changes between mean blood pressure and CO measurements that result from the use of vasopressor medications. The leading ...

Jun. 4, 2021

By Retia Medical, LLC

The Big Picture: GE Healthcare`s Latest Acquisition Could Help Open a New Chapter in Precision Health

Julia Casey is a biochemical engineer by training, but she is also a dealmaker at heart. “I like doing deals,” says Casey, who serves as general manager of GE Healthcare’s Pharmaceutical Diagnostics Molecular Imaging business. “I like dealing with startups and thinking how we can leverage their skills and bring them in so we can really see the benefits of everything ...

May 28, 2021

By GE Renewable Energy

Landmark study confirms that controlled blood pressure is key to prevent stroke, heart disease

Follow-up data from the landmark SPRINT study of the effect of high blood pressure on cardiovascular disease have confirmed that aggressive blood pressure management — lowering systolic blood pressure to less than 120 mm Hg — dramatically reduces the risk of heart disease, stroke, and death from these diseases, as well as death from all causes, compared to lowering ...

May 24, 2021

By Cardiox Corporation

Creative Enzymes Launches Advanced Neuraminidase for Flu Vaccine Development

Creative Enzymes, a professional enzyme provider located in New York, always hammers at researches and trials in order to provide customers with various enzymes as many as possible. Last week, the product manager of Creative Enzymes announced the launch of neuraminidase, which is expected to further develop a new universal influenza vaccine. Neuraminidase is a drug target to prevent the spread ...

May 5, 2021

By Creative Enzymes

Digital revolution in the healthcare industry

The Covid-19 pandemic has left a devastating mark on the US healthcare system. Struggling nurses and doctors have revealed the cracks that exist within the system and are demanding change to improve their lives and the well-being of their patients. A digital revolution has been started in the US healthcare industry, giving hope to those who have dedicated their lives to it. A medical trend ...

Apr. 27, 2021

By C&A Scientific

Detailed Introduction to Clinical Significance of Amylase

As a kind of enzymes for diagnostic use. Serum amylase (AMS) is the main type of amylase in serum. It belongs to glycoside chain hydrolase, which is mainly derived from the pancreas. In addition, there are also a small amount of secretion in the proximal duodenum, lung, uterus, and breast during lactation. Amylase plays an important role in the digestion of polysaccharide compounds in food. The ...

Apr. 26, 2021

By Creative Enzymes

AI’s Evolving Role in Monitoring and Treating Sleep Disorders

Obstructive sleep apnea (OSA) is a serious and life-threatening condition. Approximately 5.9 million adults are diagnosed with OSA, but as many as 23 million people are estimated to be dealing with OSA yet go undiagnosed. The impact on health can be significant, ranging from inconveniences to life-threatening illnesses. Obstructive sleep apnea can cause disrupted sleep for both OSA sufferers and ...

Apr. 17, 2021

By Oxitone Medical

Seeing the Unseen: These Machines Helped Unveil Secrets of the Human Body

Thomas Edison’s light bulb patent was 15 years old when Wilhelm Roentgen discovered X-rays and proved their power by imaging the bones inside his wife's hand. “I've seen my death,” she reportedly said after seeing the picture. But engineer and polymath Elihu Thomson, who together with Edison and J.P. Morgan co-founded GE in 1892, had longevity in mind. A year after ...

Apr. 15, 2021

By GE Renewable Energy

Application of Enzyme Detection in Clinical Diagnosis

Serum enzyme tests have been used in clinical practice for a long time, such as increased amylase activity in serum and urine of patients with acute pancreatitis. In the 1930s, some scholars reported that the determination of serum lipase and alkaline phosphatase activities is helpful for the diagnosis of pancreatitis and bone diseases, respectively. After the 1950s, the application of serum ...

Apr. 14, 2021

By Creative Enzymes

Top 5 challenges facing OBGYNs

Although clinicians aim to provide the best service possible, OBGYNs worldwide continue to face widespread obstacles in delivering treatment. We spoke with international experts to hear their input on the five biggest challenges facing OBGYNs around the world. Fear of treatment and diagnosis For many women, psychological factors, such as fear of painful tests and anxiety of diagnosis, play a ...

Apr. 13, 2021

By MobileODT

Potent anti-tumor activity against patient CLL, MM and AML cells by LAVA-051, a bispecific Vγ9Vδ2-T and type 1 NKT cell engager targeting CD1d

Bispecific antibodies that target tumors by engaging innate-like T cell subsets with inherent antitumor activity Bispecific antibodies that target tumors by engaging innate-like T cell subsets with inherent antitumor activity CD1d can be expressed by several hematologic malignancies Bispecific Vγ9Vδ2-T cell engager Unique ability to also trigger type 1 natural killer T (NKT) ...

Apr. 10, 2021

By LAVA Therapeutics N.V.

Into the future with breath analysis

Human breath contains up to a thousand volatile organic compounds that, when analysed, can tell a story about a body’s state of health. These chemical compounds reflect the end processes of metabolic pathways. Patterns of compound peaks form ‘signatures’ when breath is analysed into its components and it is these signatures that allow for disease conditions to be identified. ...

Apr. 9, 2021

By Imspex Diagnostics Ltd.

Sound Engineering: From Big Cities to Rainforests, Pocket-Size Ultrasound Helps Save Lives Around the World

Last year, Dr. Yale Tung Chen, an emergency medicine clinician in hard-hit Madrid, Spain, became one of a handful of clinicians around the world testing Vscan Air™, a handheld, wireless ultrasound scanner developed by engineers at GE Healthcare. The device, which GE Healthcare released for sale in the U.S. and Europe in March, beamed images from the ultrasound probe to an app on his ...

Apr. 5, 2021

By GE Renewable Energy

Neura’s behavioral intelligence provides key insights about the aging population - Case study

We used behavioral intelligence insights focused on sociability, mobility, and independence in order to monitor the decline of the aging population for best care and resource allocation. Once an elderly person begins declining in one of these three areas, typically that indicates a turning point in their health moving forward. Background Neura and Dan Ariely’s Kayma, teamed up to work ...

Apr. 5, 2021

By Neura, Inc.

Novel, Smaller and More Powerful CTLA4 Inhibitors for the Treatment of Solid Tumors

Abstract Immune checkpoint inhibitors (ICIs) have obtained durable responses in many cancers, making it possible to foresee their potential in improving the health of cancer patients. However, immunotherapies are limited at the moment to a minority of patients and there is a need for a better understanding of the basic molecular mechanisms and functions of pivotal immune molecules. Immune ...

Apr. 1, 2021

By Atomwise Inc.

RARE ANSWERS™: A System to Improve Patient Outcomes - Case study

At Alexion, our mission is to transform the lives of people affected by rare diseases and devastating conditions. In addition to developing and delivering life-changing medicines, this mission drives us to seek opportunities to advance innovative solutions to system-wide challenges faced by rare disease patients, such as the “diagnostic odyssey.” What is the Diagnostic Odyssey? ...

Mar. 26, 2021

By Alexion Pharmaceuticals, Inc.

Why is Nafion Tubing the solution to moisture in Pulmonary Function Testing?

Nafion is a polymer that can add/remove select materials, including water vapor, to a gas stream through a first order kinetic reaction (a chemical reaction). Because it’s non-porous, other molecules cannot pass through it. This unique property makes it ideal for medical applications such as removing water vapor from breath samples or adding humidity to gas samples for therapeutic ...

Mar. 22, 2021

By Perma Pure LLC - a Halma Company

Force Myography to Control Robotic Upper Extremity Prostheses: A Feasibility Study

Advancement in assistive technology has led to the commercial availability of multi-dexterous robotic prostheses for the upper extremity. The relatively low performance of the currently used techniques to detect the intention of the user to control such advanced robotic prostheses, however, limits their use. This article explores the use of force myography (FMG) as a potential alternative to ...

Mar. 19, 2021

By BioInteractive Technologies,